Achieving cost savings in NIPT by enabling greater flexibility in blood collection tube choice
Home / Your Expert / Achieving cost savings in NIPT by enabling greater flexibility in blood collection tube choice
Achieving cost savings in NIPT by enabling greater flexibility in blood collection tube choice
Yourgene Health spoke with Dr Keith Byron, Chief Operating Officer at LifeStrands Genomics, a market leader of accredited clinical laboratory services and solutions in southeast Asia, including non-invasive prenatal testing (NIPT).